Matthew L. Posard (Director) sold ~$329K of Halozyme
Scheduled in advanceLoading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
CEO exercised or converted 20K HALO derivative securities
Traded Aug 17, 2026 · Filed Aug 20, 2026
- 20K
- Shares · @ $18.41
Why it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 17, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 20, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001159036-26-000108